Adverse Event Clinical Research R4 Backport, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-backport-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationRequest
Resource MedicationRequest "medication-request-example-kadcyla1"
status: active
intent: order
medication: KADCYLA (RxNorm#1371046)
subject: Patient/patient-example-kaitlyn-b1 " HAMMER"
authoredOn: 2020-03-15
requester: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
dosageInstruction
text: Kadcyla IV at 3.6mg
timing: Starting 2020-04-03, Once
route: Intravenous route (qualifier value) (SNOMED CT#47625008)
doseAndRate
maxDosePerAdministration: 1